Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada (English, HTML)

View metadata and access the original English HTML file: Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada.

Format

HTML

Access

file-only

Publisher-reported update

2021-06-02

Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.

Access original file